ENTOURAGE PARTICIPAÇÕES S.A.

ENTOURAGE

Pharmaceutical research and development for medicines including cannabinoids and/or cannabidiol (CBD), with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, for the treatment of refractory epilepsy, epilepsy, autism and anxiety; scientific and medical research in the field of cannabinoids and/or cannabidiol (CBD) contained medicines, with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, for the treatment of refractory epilepsy, epilepsy, autism and anxiety;

ENTOURAGE PHYTOLAB

The mark consists of the stylized word ENTOURAGE in black above the stylized word PHYTOLAB in aquamarine, with a circle to the left formed by six equally-spaced dart shaped elements with the three elements in the top half of the circle in aquamarine and the three elements in the bottom half of the circle in black, and an aquamarine triangle at the center of the circle.;Medicines for the treatment of refractory epilepsy, epilepsy, autism, anxiety including cannabinoids and/or cannabidiol (CBD), with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;The color(s) black, and aquamarine is/are claimed as a feature of the mark.;Pharmaceutical research and development for medicines including cannabinoids and/or cannabidiol (CBD), with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, for the treatment of refractory epilepsy, epilepsy, autism and anxiety; scientific and medical research in the field of cannabinoids and/or cannabidiol (CBD) contained medicines, with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, for the treatment of refractory epilepsy, epilepsy, autism and anxiety;